Complete reperfusion is required for maximal benefits of mechanical thrombectomy in stroke patients

Ángel Chamorro, Jordi Blasco, Antonio López, Sergio Amaro, Luis San Román, Laura Llull, Arturo Renú, Salvatore Rudilosso, Carlos Laredo, Victor Obach, Xabier Urra, Anna M Planas, Enrique C Leira, Juan Macho, Ángel Chamorro, Jordi Blasco, Antonio López, Sergio Amaro, Luis San Román, Laura Llull, Arturo Renú, Salvatore Rudilosso, Carlos Laredo, Victor Obach, Xabier Urra, Anna M Planas, Enrique C Leira, Juan Macho

Abstract

A mTICI 2b or a mTICI 3 score are currently considered success following mechanical thrombectomy (MT) in acute stroke but is undetermined whether the two scores translate equivalent outcomes. We present a single-center, retrospective cohort of patients with anterior circulation stroke treated with MT and achieving a final mTICI score 2b or 3. A multimodal CT at baseline and a multimodal MRI at 24 hours assessed the growth of the infarct, and the modified Rankin Scale (mRS) assessed functional outcome at 90 days. The primary outcome was the shift analysis of the mRS at day 90 in ordinal regression adjusted for covariates (age, sex, pretreatment NIHSS score, target occlusion, infarct core, pretreatment alteplase), and the collateral score. Infarct growth was explored in a similarly adjusted multiple linear regression model. MT was started within a median of 285 minutes of symptom onset; 51 (41%) patients achieved a mTICI 2b, and 74 (59%), a mTICI 3. mTICI 3 resulted in better mRS score transitions than mTICI 2b (odds ratio 2.018 [95% CI 1.033-3.945], p = 0. 040), and reduced infarct growth (p = 0.002). We conclude that in patients with acute stroke receiving MT, success should be redefined as achieving a mTICI 3 score.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Distribution of mRS scores at 90 days. Proportions of patients within each score category on the 7-point scale (where 0 indicates no symptoms and 6 indicates death) at 90 days, by mTICI score. mRS = modified Rankin Scale.
Figure 2
Figure 2
Box-whisker plot of infarct volume on DWI-MRI at 24 hours of stroke onset in 51 patients with mTICI 2b and 74 with mTICI 3 (boxes, 25 to 75% interquartile range [IQR]; central horizontal bars, median; outer horizontal bars, 10 to 90% IQR).

References

    1. Jovin TG, et al. REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372:2296–2306. doi: 10.1056/NEJMoa1503780.
    1. Saver JL, et al. SWIFT PRIME Investigators. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015;372:2285–2295. doi: 10.1056/NEJMoa1415061.
    1. Goyal M, et al. ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372:1019–1030. doi: 10.1056/NEJMoa1414905.
    1. Campbell BC, et al. EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372:1009–1018. doi: 10.1056/NEJMoa1414792.
    1. Berkhemer OA, et al. MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11–20. doi: 10.1056/NEJMoa1411587.
    1. Tomsick T, et al. Interventional Management of Stroke II Investigators. Revascularization results in the Interventional Management of Stroke II trial. AJNR Am J Neuroradiol. 2008;29:582–587. doi: 10.3174/ajnr.A0843.
    1. Zaidat OO, et al. Cerebral Angiographic Revascularization Grading (CARG) Collaborators. STIR Revascularization working group. STIR Thrombolysis in Cerebral Infarction (TICI) Task Force. Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke. 2013;44:2650–2663. doi: 10.1161/STROKEAHA.113.001972.
    1. The IMS investigators. The Interventional Management of Stroke (IMS) II Study. Stroke. 38, 2127–2135 (2007).
    1. Khatri P, et al. Interventional Management of Stroke III Investigators. Methodology of the Interventional Management of Stroke III Trial. Int J Stroke. 2008;3:130–137. doi: 10.1111/j.1747-4949.2008.00151.x.
    1. Goyal M, et al. 2C or not 2C: defining an improved revascularization grading scale and the need for standardization of angiography outcomes in stroke trials. J Neurointerv Surg. 2014;6:83–86. doi: 10.1136/neurintsurg-2013-010665.
    1. Kleine JF, Wunderlich S, Zimmer C, Kaesmacher J. Time to redefine success? TICI 3 versus TICI 2b recanalization in middle cerebral artery occlusion treated with thrombectomy. J Neurointerv Surg. 2017;9:117–121. doi: 10.1136/neurintsurg-2015-012218.
    1. Powers WJ, et al. American Heart Association Stroke Council. 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2015;46:3020–3035. doi: 10.1161/STR.0000000000000074.
    1. Inoue M, et al. DEFUSE 1 and 2 Investigators. Clinical outcomes strongly associated with the degree of reperfusion achieved in target mismatch patients: pooled data from the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution studies. Stroke. 2013;44:1885–1890. doi: 10.1161/STROKEAHA.111.000371.
    1. Soares BP, Chien JD, Wintermark M. MR and CT monitoring of re-canalization, reperfusion, and penumbra salvage everything that recanalizes does not necessarily reperfuse. Stroke. 2009;40:42. doi: 10.1161/STROKEAHA.108.526814.
    1. Almekhlafi MA, et al. Not all “successful” angiographic reperfusion patients are an equal validation of a modified TICI scoring system. Interv Neuroradiol. 2014;20:21–27. doi: 10.15274/INR-2014-10004.
    1. Dargazanli C, et al. Impact of Modified TICI 3 versus Modified TICI 2b Reperfusion Score to Predict Good Outcome following Endovascular Therapy. AJNR Am J Neuroradiol. 2017;38:90–96. doi: 10.3174/ajnr.A4968.
    1. Yoo AJ, et al. Refining angiographic biomarkers of revascularization: improving outcome prediction after intra-arterial therapy. Stroke. 2013;44:2509–2512. doi: 10.1161/STROKEAHA.113.001990.
    1. Linfante I, et al. Predictors of poor outcome despite recanalization: a multiple regression analysis of the NASA registry. J Neurointerv Surg. 2016;8:224–229. doi: 10.1136/neurintsurg-2014-011525.
    1. Adams HP, Jr., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of ORG 10172 in Acute Stroke Treatment. Stroke. 1993;24:35–41. doi: 10.1161/01.STR.24.1.35.
    1. Abilleira S, et al. Outcomes of intravenous thrombolysis after dissemination of the stroke code and designation of new referral hospitals in Catalonia: the Catalan Stroke Code and Thrombolysis (Cat-SCT) Monitored Study. Stroke. 2011;42:2001–2006. doi: 10.1161/STROKEAHA.110.605030.
    1. Hacke W, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II) Lancet. 1998;352:1245–1251. doi: 10.1016/S0140-6736(98)08020-9.
    1. Renú A, et al. Brain hemorrhage after endovascular reperfusion therapy of ischemic stroke: a threshold-finding whole-brain perfusion CT study. J Cereb Blood Flow Metab. 2017;37:153–165. doi: 10.1177/0271678X15621704.
    1. Tan IY, et al. CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct. Am J Neuroradiol. 2009;30:525–531. doi: 10.3174/ajnr.A1408.
    1. Saver JL, et al. HERMES Collaborators. Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: A meta-analysis. JAMA. 2016;316:1279–1288. doi: 10.1001/jama.2016.13647.
    1. Latchaw RE, et al. American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, and the Interdisciplinary Council on Peripheral Vascular Disease. Recommendations for imaging of acute ischemic stroke: a scientific statement from the American Heart Association. Stroke. 2009;40:3646–3678. doi: 10.1161/STROKEAHA.108.192616.
    1. Marks MP, et al. Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution 2 Investigators. Effect of collateral blood flow on patients undergoing endovascular therapy for acute ischemic stroke. Stroke. 2014;45:1035–1039. doi: 10.1161/STROKEAHA.113.004085.
    1. Dalkara T, Arsava EM. Can restoring incomplete microcirculatory reperfusion improve stroke outcome after thrombolysis? J Cereb Blood Flow Metab. 2012;32:2091–2099. doi: 10.1038/jcbfm.2012.139.
    1. Desilles JP, et al. Alteplase reduces downstream microvascular thrombosis and improves the benefit of large artery recanalization in stroke. Stroke. 2015;46:3241–3248. doi: 10.1161/STROKEAHA.115.010721.
    1. Yemisci M, et al. Pericyte contraction induced by oxidative– nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nat Med. 2009;15:1031–1037. doi: 10.1038/nm.2022.
    1. Chamorro A, et al. and URICO-ICTUS Investigators. Uric acid therapy improves the outcomes of stroke patients treated with intravenous tissue plasminogen activator and mechanical thrombectomy. Int J Stroke. 2017;12:377–382. doi: 10.1177/1747493016684354.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit